Healthcare -
Biotechnology - NASDAQ - US
$ 6.74
2.43 %
$ 686 M
Market Cap
-14.98
P/E
TRVI - CHANGE IN WORKING CAPITAL
Change in Working Capital TRVI - Trevi Therapeutics, Inc.
6.83 M
LAST VALUE
174.70%
2 YEAR CAGR
34.07%
5 YEAR CAGR
0.00%
10 YEAR CAGR